• Home

  • Overview
  • CDI Faculty
• Application

  • Selection Criteria
  • Important Dates
• F.A.Q.

  • Testimonials
  • Contact
  • Important Links
• Log In

CDI Faculty

Christina Mangurian, M.D. Dr. Mangurian has received a NARSAD Young Investigator Award, the APIRE/Lilly Schizophrenia Research Fellowship, and most recently a UCSF CTSI Career Development Award. Dr. Mangurian is currently the Director of the UCSF/SFGH Public Psychiatry Fellowship, the first such fellowship in California and one focused on an implementation research project. Dr. Mangurian has also started a weekly seminar series at San Francisco General Hospital named "Community Psychiatry Research Seminar" and aimed at helping psychiatry trainees and clinical faculty learn about research ongoing in the department and pursue their own research interests. She is also responsible for working with community service agencies to improve patient flow and quality of care received by people with mental illness who are served at the hospital.

Positions

• Director, UCSF/SFGH Public Psychiatry Fellowship, Department of Psychiatry, San Francisco General Hospital
• Director, Community Psychiatry Research Seminar, Department of Psychiatry, San Francisco General Hospital
• Assistant Clinical Professor of Psychiatry, University of California at San Francisco

Education

• M.D., 2003, University of California at San Francisco, Medicine

Relevant Publications

• Mangurian C, Miller G, Jackson C, Li H, Essock S, Sederer LI. Implementation of state-wide physical health screening in outpatient mental health clinics: the New York State Office of Mental Health Outpatient Health Indicators Initiative. Psychiatric Serv. 2010;61(4):346-8.
• Mangurian C, Fuentes-Afflick E, Newcomer J. Risks from antipsychotic medications in children and adolescents. JAMA. 2010;303(8):729.
• Mangurian C, Stowe M, Devlin M. Obesity treatment for urban, low-income latinos with severe mental illness. Psychiatric Serv. 2009;60(8):1139.
• Mangurian C, Harre A, Reliford A, Booty A, Cournos F. Improving support of residents after a patient suicide: a residency case study. Acad Psychiatry. 2009;33(4):278-81.
• Amiel JM, Mangurian C, Ganguli R, Newcomer JW. Addressing cardiometabolic risk during treatment with antipsychotic medications. Curr Opinions in Psychiatry. 2009;21(6):613-618.

Funding for this conference was made possible (in part) by GRANT R25MH090947 from the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health.